Intapp (INTA): Assessing Valuation After Introducing Growth-Focused Chief Marketing Officer Dustin Sedgwick

If you have been watching Intapp (INTA) lately, the company’s decision to welcome Dustin Sedgwick as its new Chief Marketing Officer has probably caught your eye. Sedgwick, who brings strong credentials from J.P. Morgan, Microsoft, and Google, steps into this role at a time when the company is indicating a push to boost its marketing efforts and, possibly, its growth strategy. Leadership changes like this often make investors wonder if this is the point where Intapp shifts gears or if there is more happening beyond the headlines.

Market reaction has been a mix of cautious optimism and a wait-and-see approach. Over the past month, Intapp saw its shares jump by 23%, a notable rebound even as the stock remains in negative territory year-to-date and over the past quarter. Still, the longer-term picture is mixed, with just a marginal 1% gain in the last year but a much stronger return for investors who have held on for three years.

With fresh leadership and momentum starting to build again, investors may be asking whether Intapp is at an attractive valuation or if the market has already priced in Sedgwick’s growth-focused strategy.

Advertisement

Most Popular Narrative: 30% Undervalued

According to the most popular market narrative, Intapp is trading well below its estimated fair value. Analysts see considerable upside ahead based on several high-conviction growth drivers already set in motion by the company's leadership.

Intapp's recent investments in AI capabilities, including the launch of Intapp DealCloud Activator and the transformed Intapp Time product, are designed to drive client engagement and operational efficiencies. These innovations are expected to bolster revenue by enhancing product appeal and encouraging cloud adoption among existing and potential clients.

Curious how Intapp's transformation could reward shareholders? The secret recipe blends ambitious revenue targets, major profit expansion, and confidence in a high future earnings multiple. Which bold assumptions set the foundation for such a strong fair value? Keep reading to uncover the key drivers that have the market buzzing with optimism.

Result: Fair Value of $64.75 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, unexpected challenges in integrating acquisitions or setbacks during the cloud transition could limit Intapp's future growth and disrupt optimistic forecasts.

Find out about the key risks to this Intapp narrative.

Another View: Multiples Paint a Different Picture

While analysts believe Intapp is undervalued based on future growth and ambitious targets, a look at its current price-to-sales ratio compared to the industry tells a more cautious story. This suggests the shares might be expensive. Which perspective could prove right as the company evolves?

See what the numbers say about this price — find out in our valuation breakdown.
NasdaqGS:INTA PS Ratio as at Sep 2025
NasdaqGS:INTA PS Ratio as at Sep 2025
Stay updated when valuation signals shift by adding Intapp to your watchlist or portfolio. Alternatively, explore our screener to discover other companies that fit your criteria.

Build Your Own Intapp Narrative

If you want to look deeper or think a different story fits the facts, you can easily build your own perspective in just a few minutes. Do it your way.

A good starting point is our analysis highlighting 2 key rewards investors are optimistic about regarding Intapp.

Looking for more investment ideas?

Act now to position yourself ahead of the crowd. If you want results, these handpicked opportunities could power up your portfolio and unlock your next big winner.

  • Zero in on under-appreciated bargains and secure potential value before the market catches on with our undervalued stocks based on cash flows.
  • Tap into the booming world of artificial intelligence by tracking companies at the forefront of tech evolution using our AI penny stocks.
  • Capture steady returns from companies rewarding shareholders with impressive yields. Start with our selection of dividend stocks with yields > 3%.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Kshitija Bhandaru

Kshitija Bhandaru

Kshitija (or Keisha) Bhandaru is an Equity Analyst at Simply Wall St and has over 6 years of experience in the finance industry and describes herself as a lifelong learner driven by her intellectual curiosity. She previously worked with Market Realist for 5 years as an Equity Analyst.

About NasdaqGS:INTA

Intapp

Through its subsidiary, Integration Appliance, Inc., provides AI-powered solutions in the United States, the United Kingdom, and internationally.

High growth potential with excellent balance sheet.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1157.5% undervalued
47 users have followed this narrative
2 users have commented on this narrative
7 users have liked this narrative
WE
WealthAP
NOVO B logo
WealthAP on Novo Nordisk ·

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Fair Value:DKK 407.7721.4% undervalued
67 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
VA
ValueInvestingSubstack
ZTS logo
ValueInvestingSubstack on Zoetis ·

Zoetis down -50% over the past year

Fair Value:US$92.9218.9% undervalued
23 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
CE
CentryResearch
LEU logo
CentryResearch on Centrus Energy ·

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

Fair Value:US$19013.7% undervalued
24 users have followed this narrative
0 users have commented on this narrative
10 users have liked this narrative

Updated Narratives

WI
WisetoWealth
PYPL logo
WisetoWealth on PayPal Holdings ·

The Underrated Transformation of a Digital Payments Giant

Fair Value:US$90.3137.8% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BL
Blagget
TERA logo
Blagget on Terra Balcanica Resources ·

The C$4M Explorer Positioned to Become Europe's First Antimony Mine

Fair Value:CA$0.487.5% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DA
CHTR logo
david_6nroa on Charter Communications ·

Charter is undervalued - Here's why.

Fair Value:US$87.0741.6% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.919.1% undervalued
81 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28026.1% undervalued
185 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.6% undervalued
71 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0